NCT02948933View on ClinicalTrials.gov

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

CompletedOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

December 14, 2016

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Dengue FeverDengue Hemorrhagic Fever
All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02948933 - Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine | Biotech Hunter | Biotech Hunter